Cytotheryx intends to build a platform technology company through which multiple clinical programs are advanced, including liver assist devices and cell therapy. As millions of people in the United States live with liver disease, we aim to support the development of critical therapeutics to change and save lives. Using our platform technology, we envision a future with expanded applications for primary human hepatocytes, allowing for a new gold standard in toxicology and metabolic studies in drug discovery and enabling more opportunity for liver disease research and development of therapeutics for liver failure, liver disease, and rare diseases.